GHRP-6: what it is and what the evidence says
A releasing peptide studied for its relationship with growth hormone signaling and appetite stimulation. It activates the ghrelin receptor in the pituitary and the hypothalamus, amplifies the GHRH signal, and eases the somatostatin brake.
Last reviewed: August 16, 2026 · How we verify this
The ground it plays on
Hormones work in axes: a signal from the brain tells a gland to release another hormone, and so on down the chain, with brakes that shut the process off. Intervening at one point has consequences both upstream and downstream. That is why this is the group where professional assessment stops being a recommendation and becomes essential.
What it is studied for
Recovery, appetite, body composition.
There is a distinction that almost always gets lost. A compound being studied for something is not the same as achieving it. And even where it works in a dish or in a mouse, that says little about whether it works in a person or whether the benefit is worth the risk. The section below therefore carries more weight than everything above it.
What the human evidence says
It has been given to people many times, almost always in acute physiology studies or as a diagnostic test of GH secretion, including the combined test with GHRH that The Lancet published in 2000. Cuba has a pharmacokinetic study in nine healthy volunteers (2013) and a phase 1 safety trial in 18 (2014), with no serious adverse events.
The limitation that matters most
There are still no efficacy trials of prolonged administration on muscle mass, fat, or strength, and no long-term safety data. Its effect on GH depends on hypothalamic GHRH and comes with rises in ACTH, cortisol, prolactin, and appetite, whose course under sustained use remains to be studied.
Regulatory status
It is not approved as a medicine by any agency. In the United States, the FDA lists it among the substances with possible risks for pharmacy compounding (page current as of April 2026). In sport, WADA prohibits it at all times under section S2.2.4 of the 2026 list.
Status can change and varies by country. Always verify the rules in force where you live before drawing conclusions.
Cautions and context
It may markedly increase appetite; it affects hormonal axes. It briefly raises ACTH, cortisol, and prolactin, which are measured along with glucose before and during use.
Have a professional assess it before you start if you have diabetes or impaired glucose, high prolactin or cortisol, a history of binge eating or of cancer, and during use if your goal is weight related.
What this page cannot give you
A reference page can take you this far. You know what GHRP-6 is and where its research stands, which already puts you ahead of most readers. Four questions remain that no encyclopedia can answer for you, because the answers depend on your own situation:
- What would you measure beforehand, so that later you could tell whether anything actually changed?
- What would you watch along the way, and how consistently?
- What would you ask a professional, and in how much detail, so you do not walk out with a textbook answer?
- What would make you stop?
That is what the course is for
PeptiXtreme is ${CIF.LECCIONES} lessons that hand out no numbers. Each one ends with your starting point, what to watch along the way, the specific questions you take to a professional and the signals that mean stop. It includes per-module exams, a Certificate of Completion with a verifiable certificate ID, a Progress Tracker to follow how you are doing, and a human advisor you can actually write to.
See the course → Or measure your judgment, freeReferences
Every entry links to its record on PubMed, the US National Library of Medicine database. Open them and check. We would rather have a reader who verifies than one who takes our word for it.
- Pharmacokinetic study of Growth Hormone-Releasing Peptide 6 (GHRP-6) in nine male healthy volunteershuman Eur J Pharm Sci · 2013 · PMID 23099431 →
- Growth hormone (GH)-releasing peptide-6 requires endogenous hypothalamic GH-releasing hormone for maximal GH stimulationhuman J Clin Endocrinol Metab · 1998 · PMID 9543138 →
- Determination of growth hormone releasing peptides metabolites in human urine after nasal administration of GHRP-1, GHRP-2, GHRP-6, Hexarelin, and Ipamorelinhuman Drug Test Anal · 2015 · PMID 25869809 →
- Growth hormone releasing hexapeptide-6 (GHRP-6) test in the diagnosis of GH-deficiencyreview J Pediatr Endocrinol Metab · 1996 · PMID 8887178 →
- Growth hormone-releasing peptidesreview Eur J Endocrinol · 1997 · PMID 9186261 →
- Use of growth-hormone-releasing peptide-6 (GHRP-6) for the prevention of multiple organ failurepreclinical Clin Sci (Lond) · 2006 · PMID 16417467 →
- Growth hormone releasing peptide (GHRP-6) stimulates phosphatidylinositol (PI) turnover in human pituitary somatotroph cellspreclinical J Mol Endocrinol · 1995 · PMID 7772238 →
Was this page useful?
Research moves, and when something relevant changes we update the page. If you want to hear about it for GHRP-6 or any other compound, leave your email. The introductory guide comes with it. No spam, no list-selling; one click to unsubscribe.
Frequently asked questions
What is GHRP-6?
A releasing peptide studied for its relationship with growth hormone signaling and appetite stimulation. It activates the ghrelin receptor in the pituitary and the hypothalamus, amplifies the GHRH signal, and eases the somatostatin brake. It is studied within the area of hormonal/sexual.
Is there human evidence for GHRP-6?
It has been given to people many times, almost always in acute physiology studies or as a diagnostic test of GH secretion, including the combined test with GHRH that The Lancet published in 2000. Cuba has a pharmacokinetic study in nine healthy volunteers (2013) and a phase 1 safety trial in 18 (2014), with no serious adverse events.
Is it approved by any health agency?
It is not approved as a medicine by any agency. In the United States, the FDA lists it among the substances with possible risks for pharmacy compounding (page current as of April 2026). In sport, WADA prohibits it at all times under section S2.2.4 of the 2026 list.
What is the dose of GHRP-6?
We do not publish dosages. This is not an oversight. No single figure works for everyone: the regimen depends on a person's medical history, on whatever medication they already take, and on the goal they are chasing, which is something a professional weighs with the case in front of them. What you can build is the ability to walk into that appointment knowing what to ask.
Where can I learn to evaluate this properly?
This page tells you what GHRP-6 is and what the evidence says. The PeptiXtreme course teaches the other half: what you would measure before considering anything, what you would watch, the specific questions you would take to a professional and when you would stop.